NASDAQ Companies

The new preclinical data further supports istaroxime clinical data from three Phase 2 studies Arrythmias can be a serious complication of […]

WEST FARGO, N.D., Jan. 02, 2024 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural […]

NOVATO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]

REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated […]

LEHI, Utah, Jan. 02, 2024 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (NASDAQ: NATR) (Nature’s Sunshine), a leading natural health […]

STAMFORD, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (the “Company”) today announced that the Company […]

WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]

LITTLE ROCK, Ark., Jan. 02, 2024 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) announced its Board of Directors […]

SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]

HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at […]